Abstract
Primary thymic adenocarcinoma of enteric type is a very rare subtype of thymic carcinoma. Choosing appropriate systemic chemotherapy for patients with unresectable or recurrent disease remain a big challenge. We present a case of 38-year-old man with primary thymic adenocarcinoma of enteric type. The patient received multiline chemotherapy. Metastatic lesions were effectively controlled by FOLFOX (oxaliplatin/5-fluorouracil/leucovorin) chemotherapy. According to the present case and the literature review, FOLFOX and XELOX (capecitabine/oxaliplatin) regimens are reasonable treatment choice for unresectable or recurrent primary thymic adenocarcinoma of enteric type, even in the first-line chemotherapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kwon AY, Han J, Cho HY, Kim S et al (2017) Cytologic characteristics of thymic adenocarcinoma with enteric differentiation: a study of four fine-needle aspiration specimens. J Pathol Transl Med 51(5):509–512. https://doi.org/10.4132/jptm.2017.03.22
Moser B, Schiefer AI, Janik S et al (2015) Adenocarcinoma of the thymus, enteric type: report of 2 cases, and proposal for a novel subtype of thymic carcinoma. Am J Surg Pathol 39(4):541–548. https://doi.org/10.1097/PAS.0000000000000359
NCCN (2022) NCCN Clinical practice guidelines in oncology-thymomas and thymic carcinomas (version 2.2022). https://www.nccn.org/professionals/physician_gls/pdf/thymic.pdf. Accessed June 2022
Maeda D, Ota S, Ikeda S et al (2009) Mucinous adenocarcinoma of the thymus: a distinct variant of thymic carcinoma. Lung Cancer 64(1):22–27. https://doi.org/10.1016/j.lungcan.2008.06.019
Kwon AY, Han J, Chu J et al (2017) Histologic characteristics of thymic adenocarcinomas: clinicopathologic study of a nine-case series and a review of the literature. Pathol Res Pract 213(2):106–112. https://doi.org/10.1016/j.prp.2016.11.012
Li M, Pu XY, Dong LH et al (2021) Metastatic thymic-enteric adenocarcinoma responding to chemoradiation plus anti-angiogenic therapy: a case report. World J Clin Cases 9(7):1676–1681
Hamahiro T, Maeda R, Ayabe T et al (2021) Primary mucinous adenocarcinoma of the thymus: a case report. Respir Med Case Rep 34:101497. https://doi.org/10.1016/j.rmcr.2021.101497
Tomoshige K, Tomoshi T, Keitaro M et al (2021) Primary mucinous adenocarcinoma of the thymus; a rare type of thymic carcinoma. Case report. SN Compr Clin Med 3(5):1233–1237. https://doi.org/10.1007/s42399-021-00839-x
Shiono A, Fujino T, Kaira K et al (2020) Primary thymic adenocarcinoma with an aggressive clinical course: an autopsy case showing signet ring cell-like features. Thorac Cancer 11(12):3609–3613. https://doi.org/10.1111/1759-7714.13700
Miller CN, Proekt I, von Moltke J et al (2018) Thymic tuft cells promote an IL-4-enriched medulla and shape thymocyte development. Nature 559(7715):627–631. https://doi.org/10.1038/s41586-018-0345-2
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author discloses no conflict of interest and no funding for the present paper.
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Gao, X. Systemic chemotherapy for unresectable or recurrent primary thymic adenocarcinoma of enteric type. Int Canc Conf J 12, 46–48 (2023). https://doi.org/10.1007/s13691-022-00575-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13691-022-00575-6